Avelumab in First-line Non-Small Cell Lung Cancer (JAVELIN Lung 100)

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleAvelumab in First-line Non-Small Cell Lung Cancer (JAVELIN Lung 100)
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsJong-Seok Lee